OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmaceuticals is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Network Pharmacology Approach for Medicinal Plants: Review and Assessment	152
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies	137
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside	134
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment	133
Lung Fibrosis after COVID-19: Treatment Prospects	124
Bone Tissue Engineering in the Treatment of Bone Defects	123
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2	121
Dietary Effects of Anthocyanins in Human Health: A Comprehensive Review	120
Drug Design by Pharmacophore and Virtual Screening Approach	115
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus	115
1,2,4-Triazoles as Important Antibacterial Agents	111
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery	109
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences	104
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review	99
Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives	98
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth	96
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer	96
COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials	96
Alginate Nanoformulation: Influence of Process and Selected Variables	92
Mycosporine-Like Amino Acids (MAAs): Biology, Chemistry and Identification Features	89
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective	88
Recent Advances in Potential Health Benefits of Quercetin	84
An Overview of Cellulose Derivatives-Based Dressings for Wound-Healing Management	77
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer	76
G-Quadruplexes and Their Ligands: Biophysical Methods to Unravel G-Quadruplex/Ligand Interactions	74

Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids	74
Silica-Based Bioactive Glasses and Their Applications in Hard Tissue Regeneration: A Review	73
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug	71
Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes	70
Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts	70
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme	69
Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges	69
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis	69
Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia	68
Periodontal Wound Healing and Tissue Regeneration: A Narrative Review	68
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity	68
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review	68
The Chemistry Behind ADCs	68
Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders	67
The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry	66
Advances in Antifungal Drug Development: An Up-To-Date Mini Review	65
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy	65
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease	65
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update	64
Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release	64
Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery	63
Wound Healing Promotion by Hyaluronic Acid: Effect of Molecular Weight on Gene Expression and In Vivo Wound Closure	62
Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies	61
Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview	61
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury	61
Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research	60
Recent Advances in Green Synthesis, Characterization, and Applications of Bioactive Metallic Nanoparticles	60
Strategies for Improving Peptide Stability and Delivery	59
2020 FDA TIDES (Peptides and Oligonucleotides) Harvest	57
Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2	56
The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure	55
Extracellular Vesicles in Skin Wound Healing	55
Using Carbomer-Based Hydrogels for Control the Release Rate of Diclofenac Sodium: Preparation and In Vitro Evaluation	55
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2	55